STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY -- STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY -- CONTENTS -- PREFACE -- INTRODUCTION -- REFERENCES -- NEUROGENESIS AND ALZHEIMER'S DISEASE -- ABSTRACT -- 1. INTRODUCTION -- 2. NEUROGENESIS IN ALZHEIMER'S DISEASE -- 3. EFFECT ON NEUROGENESIS OF DRUGS USED TO TREAT AD -- 4. STEM CELL THERAPY FOR THE TREATMENT OF AD -- 5. CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- NEUROGENESIS AND THE EFFECT OF ANTIDEPRESSANTS -- ABSTRACT -- 1. INTRODUCTION -- 2. NEUROGENESIS CONTRIBUTES TO THE THERAPEUTIC EFFECTS OF ANTIDEPRESSANTS -- 3. A NEUROGENIC THEORY OF DEPRESSION -- 4. CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- ADULT NEURAL STEM CELLS AND CELLULAR THERAPY -- ABSTRACT -- 1. INTRODUCTION -- 2. ADULT NEUROGENESIS AND NEURAL STEM CELLS -- 3. ADULT NEURAL STEM CELLS AND CELLULAR THERAPY -- 4. ADULT NEURAL STEM CELLS: A MODEL OF CHOICE FOR CELLULAR THERAPY FOR CNS DISEASES AND INJURIES -- 5. CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- STEM CELL ENGINEERING FOR CELL-BASED THERAPY -- ABSTRACT -- 1. INTRODUCTION -- 2. CELL ENGINEERING TO DERIVE ESCS WITHOUT THE DESTRUCTION OF EMBRYOS -- 3. ADULT NEURAL STEM CELL ENGINEERING -- 4. CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- HUCNS-SC STEM CELLS -- SUMMARY -- ABSTRACT -- 1. INTRODUCTION -- 2. SYNTHESIS AND SAR -- 3. PRECLINICAL DEVELOPMENT -- 4. METABOLISM AND PHARMACOKINETICS -- 5. TOXICITY -- 6. CLINICAL DEVELOPMENT -- 7. SIDE EFFECTS AND CONTRAINDICATIONS -- 8. PATENT SUMMARY -- 9. CURRENT OPINION -- 10. LICENSING -- 11. DEVELOPMENT HISTORY -- 12. LITERATURE CLASSIFICATIONS -- 13. ASSOCIATED PATENT -- ACKNOWLEDGMENTS -- REFERENCES -- OTI-010 OSIRIS THERAPEUTICS/JCR PHARMACEUTICALS -- ABSTRACT -- 1. INTRODUCTION -- 2. SYNTHESIS AND SAR -- 3. PRECLINICAL DEVELOPMENT.

4. METABOLISM AND PHARMACOKINETICS -- 5. TOXICITY -- 6. CLINICAL DEVELOPMENT -- 7. SIDE EFFECTS AND CONTRAINDICATIONS -- 8. PATENT SUMMARY -- 9. CURRENT OPINION -- 10. LICENSING -- 11. DEVELOPMENT HISTORY -- 12. LITERATURE CLASSIFICATIONS -- 13. ASSOCIATED PATENT -- ACKNOWLEDGMENTS -- REFERENCES -- ADA-TRANSDUCED HEMATOPOIETIC STEM CELL THERAPY FOR ADA-SCID -- SUMMARY -- ABSTRACT -- 1. INTRODUCTION -- 2. SYNTHESIS AND SAR -- 3. PRECLINICAL DEVELOPMENT -- 4. METABOLISM AND PHARMACOKINETICS -- 5. TOXICITY -- 6. CLINICAL DEVELOPMENT -- 7. SIDE EFFECTS AND CONTRAINDICATIONS -- 8. PATENT SUMMARY -- 9. CURRENT OPINION -- 10. DEVELOPMENT HISTORY -- 11. LITERATURE CLASSIFICATIONS -- ACKNOWLEDGMENTS -- REFERENCES -- THERAPEUTIC POTENTIAL OF ADULT NEURAL STEM CELLS -- ABSTRACT -- 1. INTRODUCTION -- 2. NEURAL PROGENITOR AND STEM CELLS -- 3. THERAPEUTIC POTENTIAL OF ADULT NSCS -- 4. CURRENT AND FUTURE DEVELOPMENTS -- ACKNOWLEDGEMENTS -- REFERENCES -- CONCLUSION AND PERSPECTIVES: ADULT NEURAL STEM CELLS - THE PROMISE OF THE FUTURE -- ABSTRACT -- 1. INTRODUCTION -- 2. ADULT NEUROGENESIS, FACTS AND DEBATES -- 3. THE FUTURE OF ADULT NEUROGENESIS -- 4. THE PROMISE OF ADULT NEURAL STEM CELLS -- 5. CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX.